The global healthcare sector faces increasing pressure to deliver more efficient and patient-centric diagnostic services. Rising prevalence of age-related hearing loss and the critical need for early detection in pediatric populations necessitate innovations in audiology. This technology provides a competitive edge by offering a non-invasive, high-throughput solution that reduces operational costs and enhances patient satisfaction, aligning with global trends in preventative medicine and digital health.
Reduces objective hearing test time by up to 50%
Delivers high-accuracy results with low computational load
Establishes pioneering technological exclusivity until ~2041
This patent protects a comprehensive hearing test system and method, from applying amplitude-modulated sound to measuring brainwave signals, signal segmentation, similarity calculation, and final hearing determination, across six claims. The absence of similar prior art cited by the examiner indicates its pioneering nature. Successfully overcoming an initial office action demonstrates a robust and stable right, meticulously designed by experienced agents.
This patent primarily covers the signal processing and determination logic for objective hearing tests. White space exists in developing novel EEG hardware, integrating with advanced telehealth platforms, or applying AI for predictive diagnostics beyond basic hearing assessment.
Assuming a medical facility conducts 2,500 objective hearing tests annually, this technology could reduce test time by 50%, saving approximately 1,000 technician hours per year. At an estimated labor cost of $20/hour (AI est.), this translates to ~$20K/year in cost savings (AI est.). Additionally, a 20% increase in test volume due to improved efficiency, at $13.50/case (AI est.) in reimbursement, could generate ~$65K/year in increased revenue (AI est.). Total estimated economic impact: ~$85K/year (AI est.).
X: Test Efficiency & Throughput
Y: Patient Burden Reduction & Accuracy